To evaluate the cell-surface binding of nanobodies towards Trop2-positive tumor cells, we fused nanobodies with human IgG Fc to construct VHH-Fc fusions and measured fluorescent signals in NCI-N87 and MDA-MB-231 cells by flow cytometry. This evidence concerns the gene TACSTD2 and neoplasm.